About us – MagaVena
Who are we?
MagaVena is an interdisciplinary research and development company founded in 2020 by physicians, molecular biologists and plant biotechnologists who share a passion for science, nature and human health.
From the beginning, our goal has been to discover and develop bioattractors - natural, reactive plant molecules with enormous therapeutic potential - based on the most up-to-date scientific achievements, including chronomedicine and chronobiology.
Our mission: to restore the body's balance and support its regeneration, taking into account the natural biological rhythms of life.
The Story of MagaVena
2020 – Foundations
The company was founded by a team of specialists who saw the need to integrate modern science with traditional knowledge of medicinal plants. 2020 – Foundations and research on xanthohumol and COVID-19.
In the first year of our activity, we began intensive research on the effect of natural plant compounds on viral infections.
We paid particular attention to xanthohumol – a flavonoid found in hops – which in vitro studies showed antiviral potential and anti-inflammatory properties.
We analyzed the possibility of using xanthohumol as support in limiting the cytokine storm and protecting lung cells during COVID-19 infection.
This was one of our first research projects, which established the direction of MagaVen's development towards the integration of bioactive plant metabolites and the latest medical knowledge.
2022 – Research on reducing inflammation in humans
(X8 - Ksantohumol)
We expanded our activities to include research on chronic inflammation in humans.
We analyzed the effect of bioattractors on molecular inflammatory pathways (cytokines, inflammatory mediators) in relation to circadian rhythms — in line with the knowledge that inflammatory processes intensify or weaken depending on the time of day.
Our bioattractors were designed and tested to work in harmony with the body's natural immune rhythms, maximizing effectiveness and minimizing side effects.
X8 - see more
2024 – Gut Microbiota
(MAKAMALA - Rottlerine)
We have implemented research projects on bioattractors supporting the health of the intestinal microbiota in patients with Crohn's disease.
We took into account the circadian rhythm of the microbiome - the variability of its composition and enzymatic activity during the day - and the natural fluctuations of the intestinal mucosa immunity.
Thanks to this, our bioattractants not only reduce inflammation, but also stabilize the intestinal environment in the most optimal phases of the day.
Our team
MagaVena is a synergy of many fields of science:
• Clinical physicians – immunology, gastroenterology, hepatology, oncology.
• Chronobiology specialists – studies of biological rhythms and their impact on the effectiveness of therapy.
• Pharmacists – standardization of extracts and development of pharmaceutical products.
• Molecular biologists – analysis of cellular mechanisms.
• Plant biotechnologists – extraction, cultivation and optimization of bioattractor production.
• Analytical chemists – quality control, metabolomics, chemometrics.
Our values
Natural intelligence – we use biological mechanisms consistent with nature.
Chronobiology and chronomedicine – we respect the body's biological rhythms to maximize the effectiveness of therapy.
Ethics and sustainable development – we care for the environment and local communities.
Innovation and scientific foundations – we base all our activities on current, verified scientific research.
MagaVena
New natural technology